Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Raed M. Al-Zoubi, Mustafa Alwani, Omar M. Aboumarzouk, Mai Elaarag, Ahmad R. Al-Qudimat, Laxmi Ojha & Aksam Yassin. (2022) Updates on androgen replacement therapy and lower urinary tract symptoms: a narrative review. The Aging Male 25:1, pages 234-241.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Giovanni Corona, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2021) Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. The Aging Male 24:1, pages 119-138.
Read now
Read now
Huseyin Besiroglu, Murat Dursun, Alper Otunctemur & Emin Ozbek. (2017) The association between triglyceride high density lipoprotein cholesterol ratio and benign prostate hyperplasia in non-diabetic patients:a cross-sectional study. The Aging Male 20:3, pages 198-204.
Read now
Read now
Ozan Efesoy, Duygu Apa, Mesut Tek & Selahittin Çayan. (2016) The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism. The Aging Male 19:2, pages 79-84.
Read now
Read now
Kazuyoshi Shigehara, Tohru Miyagi, Takao Nakashima, Koji Izumi, Yasuhide Kitagawa, Atsushi Mizokami, Eitetsu Koh, Masayoshi Shimamura & Mikio Namiki. (2016) Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction. The Aging Male 19:2, pages 128-133.
Read now
Read now
Giorgio Ivan Russo, Tommaso Castelli, Daniele Urzì, Salvatore Privitera, Eugenia Fragalà, Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero, Vincenzo Favilla, Sebastiano Cimino & Giuseppe Morgia. (2015) Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis. The Aging Male 18:4, pages 207-216.
Read now
Read now
Giovanni Corona, Elisa Maseroli & Mario Maggi. (2014) Injectable testosterone undecanoate for the treatment of hypogonadism. Expert Opinion on Pharmacotherapy 15:13, pages 1903-1926.
Read now
Read now
Steven A. Kaplan, Edward O’Neill, Robert Lowe, Mary Hanson & Alan G. Meehan. (2013) Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS). The Aging Male 16:2, pages 48-51.
Read now
Read now
Farid Saad, Aksam A. Yassin, Ahmad Haider & Louis Gooren. (2011) Effects of testosterone on the lower urinary tract go beyond the prostate: New insights, new treatment options. Arab Journal of Urology 9:2, pages 147-152.
Read now
Read now
Toshiyasu Amano, Tetsuya Imao, Katsurou Takemae, Teruaki Iwamoto & Mariko Nakanome. (2010) Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients. The Aging Male 13:4, pages 242-246.
Read now
Read now
Articles from other publishers (51)
L. Lin, W. Wang, K. Xiao, X. Guo & L. Zhou. (2023) Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. Journal of Endocrinological Investigation.
Crossref
Crossref
Jason A. Levy, Arthur L. Burnett & Adrian S. Dobs. (2022) Testosterone Treatment and the Risk of Prostate Adverse Events. Endocrinology and Metabolism Clinics of North America 51:1, pages 123-131.
Crossref
Crossref
F. Saad. 2022. Präventionsmedizin und Anti-Aging-Medizin. Präventionsmedizin und Anti-Aging-Medizin
189
207
.
Min Ho Lee, Yu Seob Shin & Sung Chul Kam. (2021) Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms. International Neurourology Journal 25:1, pages 12-22.
Crossref
Crossref
Giulia Rastrelli, Linda Vignozzi, Giovanni Corona & Mario Maggi. (2019) Testosterone and Benign Prostatic Hyperplasia. Sexual Medicine Reviews 7:2, pages 259-271.
Crossref
Crossref
Abdulmaged M. Traish & Abraham Morgentaler. 2019. Sex Differences in Cardiovascular Physiology and Pathophysiology. Sex Differences in Cardiovascular Physiology and Pathophysiology
321
354
.
Abdulmaged M. Traish & Vanessa Johansen. (2018) Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome. The World Journal of Men's Health 36:3, pages 199.
Crossref
Crossref
Farid Saad, Gheorghe DorosKarim Sultan HaiderAhmad Haider. (2018) Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms. Investigative and Clinical Urology 59:6, pages 399.
Crossref
Crossref
Abdulmaged M. Traish. (2018) Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews 6:1, pages 86-105.
Crossref
Crossref
Karim Sultan Haider, Ahmad Haider, Gheorghe Doros & Abdulmaged Traish. (2018) Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study. Journal of Urology 199:1, pages 257-265.
Crossref
Crossref
Mauro Gacci, Arcangelo Sebastianelli & Matteo Salvi. 2018. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia. Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia
89
111
.
Giselle Bravo, Helen Massa, Roselyn Rose’Meyer, Russ Chess-Williams, Catherine McDermott & Donna J. Sellers. (2017) Effect of short-term androgen deficiency on bladder contractility and urothelial mediator release. Naunyn-Schmiedeberg's Archives of Pharmacology 390:5, pages 547-556.
Crossref
Crossref
Jasmin Katrin Badawi, Ruud Bosch, Jens Christian Djurhuus & Ann T. Hanna-Mitchell. (2017) Is testosterone important in LUT function in men and women? ICI-RS 2015. Neurourology and Urodynamics 36:4, pages 859-862.
Crossref
Crossref
Kazuyoshi ShigeharaKoji IzumiAtsushi MizokamiMikio Namiki. (2017) Testosterone Deficiency and Nocturia: A Review. The World Journal of Men's Health 35:1, pages 14.
Crossref
Crossref
Ti Lu, Ya-Han Hu, Chih-Fong Tsai, Shih-Ping Liu & Pei-Ling Chen. (2016) Applying machine learning techniques to the identification of late-onset hypogonadism in elderly men. SpringerPlus 5:1.
Crossref
Crossref
N. Enatsu, H. Miyake, T. Haraguchi, K. Chiba & M. Fujisawa. (2016) Effects of dutasteride on serum free-testosterone and clinical significance of testosterone changes. Andrologia 48:10, pages 1195-1201.
Crossref
Crossref
Mohit Khera, Ganesh Adaikan, Jacques Buvat, Serge Carrier, Amr El-Meliegy, Kostas Hatzimouratidis, Andrew McCullough, Abraham Morgentaler, Luiz Otavio Torres & Andrea Salonia. (2016) Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). The Journal of Sexual Medicine 13:12, pages 1787-1804.
Crossref
Crossref
Chen-Li Cheng & William C. de Groat. (2016) Effect of orchiectomy and testosterone replacement on lower urinary tract function in anesthetized rats. American Journal of Physiology-Renal Physiology 311:5, pages F864-F870.
Crossref
Crossref
Mohit Khera, Gregory A. Broderick, Culley C. CarsonIIIIII, Adrian S. Dobs, Martha M. Faraday, Irwin Goldstein, Lawrence S. Hakim, Wayne J.G. Hellstrom, Ravi Kacker, Tobias S. Köhler, Jesse N. Mills, Martin Miner, Hossein Sadeghi-Nejad, Allen D. Seftel, Ira D. Sharlip, Stephen J. Winters & Arthur L. Burnett. (2016) Adult-Onset Hypogonadism. Mayo Clinic Proceedings 91:7, pages 908-926.
Crossref
Crossref
T.G. Adedeji, A.A. Fasanmade & E.O. Olapade-Olaopa. (2016) An association between diet, metabolic syndrome and lower urinary tract symptoms. African Journal of Urology 22:2, pages 61-66.
Crossref
Crossref
Mohit Khera. (2016) Male hormones and men's quality of life. Current Opinion in Urology 26:2, pages 152-157.
Crossref
Crossref
Linda Vignozzi, Mauro Gacci & Mario Maggi. (2016) Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nature Reviews Urology 13:2, pages 108-119.
Crossref
Crossref
Martin Kathrins, Karen Doersch, Tony Nimeh, Arturo Canto, Craig Niederberger & Allen Seftel. (2016) The Relationship Between Testosterone-Replacement Therapy and Lower Urinary Tract Symptoms: A Systematic Review. Urology 88, pages 22-32.
Crossref
Crossref
Aaron Moore, Michael J. Butcher & Tobias S. Köhler. (2015) Testosterone Replacement Therapy on the Natural History of Prostate Disease. Current Urology Reports 16:8.
Crossref
Crossref
Ahmed A. M. Abdel-Hamid & Eyad M. T. Ali. (2015) Effect of testosterone therapy on the urinary bladder in experimental hypogonadism of rats. Journal of Molecular Histology 46:3, pages 263-272.
Crossref
Crossref
Jun Ho Lee, Yooseok Kim, Yeon Won Park & Dong-Gi Lee. (2014) Relationship Between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Total Serum Testosterone Level in Healthy Middle-Aged Eugonadal Men. The Journal of Sexual Medicine 11:5, pages 1309-1315.
Crossref
Crossref
L. Vignozzi, G. Rastrelli, G. Corona, M. Gacci, G. Forti & M. Maggi. (2014) Benign prostatic hyperplasia: a new metabolic disease?. Journal of Endocrinological Investigation 37:4, pages 313-322.
Crossref
Crossref
Giovanni Corona, Linda Vignozzi, Giulia Rastrelli, Francesco Lotti, Sarah Cipriani & Mario Maggi. (2014) Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions. International Journal of Endocrinology 2014, pages 1-14.
Crossref
Crossref
Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia & Abraham Morgentaler. (2014) A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications. European Urology 65:1, pages 115-123.
Crossref
Crossref
P. Comeglio, A. Morelli, I. Cellai, L. Vignozzi, E. Sarchielli, S. Filippi, E. Maneschi, F. Corcetto, C. Corno, M. Gacci, G.B. Vannelli & M. Maggi. (2014) Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER?. The Prostate 74:1, pages 10-28.
Crossref
Crossref
Ozan Bozkurt, Deniz Bolat, Omer Demir, Oktay Ucer, Ali Şahin, Burak Ozcift, Abdulkadir Pektaş, Tahir Turan, Bilal H Gümüş, Ertan Can, Ahmet Bolukbasi, Haluk Erol & Adil Esen. (2013) Erectile function and late-onset hypogonadism symptoms related to lower urinary tract symptom severity in elderly men. Asian Journal of Andrology 15:6, pages 785-789.
Crossref
Crossref
Akira Komiya, Mika Kino, Tomonori Kato, Hiroyoshi Suzuki, Tomohiko Ichikawa & Hideki Fuse. (2013) Correlations Among Urinary, Sexual, and Testicular Functions and Health-Related Quality of Life. Journal of Men's Health 10:3, pages 112-118.
Crossref
Crossref
Linda Vignozzi, Mauro Gacci, Ilaria Cellai, Raffaella Santi, Giovanni Corona, Annamaria Morelli, Giulia Rastrelli, Paolo Comeglio, Arcangelo Sebastanelli, Elena Maneschi, Gabriella Nesi, Cosimo De Nunzio, Andrea Tubaro, Edoardo Mannucci, Marco Carini & Mario Maggi. (2012) Fat boosts, while androgen receptor activation counteracts, BPH‐associated prostate inflammation. The Prostate 73:8, pages 789-800.
Crossref
Crossref
Peter T. K. Chan. 2013. Biennial Review of Infertility. Biennial Review of Infertility
31
48
.
Carla B. M. Gallo, Alexandre F. Miranda, Bruno Felix‐Patricio, Cristiane F. Ramos, Luiz E. M. Cardoso, Waldemar S. Costa & Francisco J. B. Sampaio. (2013) Effects of Castration and Hormone Replacement in the Urinary Bladder of Rats: Structural, Ultrastructural, and Biochemical Analysis. Journal of Andrology 33:4, pages 684-690.
Crossref
Crossref
I. A. Tyuzikov, А. G. Martov & S. Yu. Kalinchenko. (2012) New system mechanisms of pathogenesis of low urinary tract symptoms at men (literary review). Bulletin of Siberian Medicine 11:2, pages 93-100.
Crossref
Crossref
I. A. Tyuzikov, А. G. Martov & Yu. S. Kalinchenko. (2012) Influence of obesity and androgen deficiency on prostatic blood circulation. Bulletin of Siberian Medicine 11:2, pages 80-83.
Crossref
Crossref
Linda Vignozzi, Annamaria Morelli, Erica Sarchielli, Paolo Comeglio, Sandra Filippi, Ilaria Cellai, Elena Maneschi, Sergio Serni, Mauro Gacci, Marco Carini, Marie-Pierre Piccinni, Farid Saad, Luciano Adorini, Gabriella B Vannelli & Mario Maggi. (2012) Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. Journal of Endocrinology 212:1, pages 71-84.
Crossref
Crossref
Chun-Hou Liao, Han-Sun Chiang & Po-Jen Hsiao. (2011) Lower urinary tract symptoms and erectile dysfunction. Urological Science 22:4, pages 135-140.
Crossref
Crossref
Young Hwii Ko & Je Jong Kim. (2011) Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea. Asian Journal of Andrology 13:4, pages 563-568.
Crossref
Crossref
Stephanie T. Page, Lianne Hirano, Janet Gilchriest, Manjiri Dighe, John K. Amory, Brett T. Marck & Alvin M. Matsumoto. (2011) Dutasteride Reduces Prostate Size and Prostate Specific Antigen in Older Hypogonadal Men With Benign Prostatic Hyperplasia Undergoing Testosterone Replacement Therapy. Journal of Urology 186:1, pages 191-197.
Crossref
Crossref
Jing Meng, Elahe A. Mostaghel, Funda Vakar-Lopez, Bruce Montgomery, Larry True & Peter S. Nelson. (2011) Testosterone Regulates Tight Junction Proteins and Influences Prostatic Autoimmune Responses. Hormones and Cancer 2:3, pages 145-156.
Crossref
Crossref
Farid SaadLouis J Gooren. (2011) Late Onset Hypogonadism and Lower Urinary Tract Symptoms: New Insights. Korean Journal of Andrology 29:1, pages 1.
Crossref
Crossref
Firas AbdollahAlberto BrigantiNazareno SuardiFabio CastiglioneAndrea GallinaUmberto CapitanioFrancesco Montorsi. (2011) Metabolic Syndrome and Benign Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology, and Prevention. Korean Journal of Urology 52:8, pages 507.
Crossref
Crossref
Kazuyoshi ShigeharaMikio Namiki. (2011) Late-Onset Hypogonadism Syndrome and Lower Urinary Tract Symptoms. Korean Journal of Urology 52:10, pages 657.
Crossref
Crossref
Michael D. Trifiro, J. Kellogg Parsons, Kerrin Palazzi-Churas, Jaclyn Bergstrom, Charles Lakin & Elizabeth Barrett-Connor. (2010) Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men. BJU International 105:11, pages 1554-1559.
Crossref
Crossref
Julie K. Gammack. (2010) Lower Urinary Tract Symptoms. Clinics in Geriatric Medicine 26:2, pages 249-260.
Crossref
Crossref
In Ho Chang, Seung Young Oh & Sae Chul Kim. (2009) A Possible Relationship Between Testosterone and Lower Urinary Tract Symptoms in Men. Journal of Urology 182:1, pages 215-220.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 16:3, pages 260-277.
Crossref
Crossref
Bruno LunenfeldMichael Oettel. (2009) Therapeutic potential of testosterone gels. Aging Health 5:2, pages 227-245.
Crossref
Crossref
Akira Tsujimura & Akihiko Okuyama. (2008) Treatment for late-onset hypogonadism: the current situation in Japan. Journal of Men's Health 5:4, pages 342-349.
Crossref
Crossref